- Raud, Brenda;
- Roy, Dominic G;
- Divakaruni, Ajit S;
- Tarasenko, Tatyana N;
- Franke, Raimo;
- H., Eric;
- Samborska, Bozena;
- Hsieh, Wei Yuan;
- Wong, Alison H;
- Stüve, Philipp;
- Arnold-Schrauf, Catharina;
- Guderian, Melanie;
- Lochner, Matthias;
- Rampertaap, Shakuntala;
- Romito, Kimberly;
- Monsale, Joseph;
- Brönstrup, Mark;
- Bensinger, Steven J;
- Murphy, Anne N;
- McGuire, Peter J;
- Jones, Russell G;
- Sparwasser, Tim;
- Berod, Luciana
T cell subsets including effector (Teff), regulatory (Treg), and memory (Tmem) cells are characterized by distinct metabolic profiles that influence their differentiation and function. Previous research suggests that engagement of long-chain fatty acid oxidation (LC-FAO) supports Foxp3+ Treg cell and Tmem cell survival. However, evidence for this is mostly based on inhibition of Cpt1a, the rate-limiting enzyme for LC-FAO, with the drug etomoxir. Using genetic models to target Cpt1a specifically in T cells, we dissected the role of LC-FAO in primary, memory, and regulatory T cell responses. Here we show that the ACC2/Cpt1a axis is largely dispensable for Teff, Tmem, or Treg cell formation, and that the effects of etomoxir on T cell differentiation and function are independent of Cpt1a expression. Together our data argue that metabolic pathways other than LC-FAO fuel Tmem or Treg differentiation and suggest alternative mechanisms for the effects of etomoxir that involve mitochondrial respiration.